Trends in antihypertensives use among Moroccan patients

Pharmacoepidemiology and Drug Safety
Ghizlane Berrada El AziziY Cherrah

Abstract

In this study, we analyzed the consumption trends of antihypertensives in Morocco during the 1991-2010 period and the impacts after the institution of Mandatory Health Insurance and the marketing of generic drugs. We used sales data from the Moroccan subsidiary of IMS Health "Intercontinental Marketing Service". The consumption volumes were converted into defined daily doses (DDDs). Between 1991 and 2010, outpatient consumption of antihypertensives went from 4.37 to 23.14 DDD/1000 inhabitants/day, a 5.30-fold increase. In 2010, calcium channel blockers (CCBs) and angiotensin converting enzyme inhibitors (ACEI) were the most consumed (4.97 DDD/1000 inhabitants/day) for each one, followed by diuretics (4.20 DDD/1000 inhabitants/day). The most consumed products were amlodipine (4.27 DDD/1000 inhabitants/day) followed by ramipril (3.18 DDD/1000 inhabitants /day) and indapamide (1.72 DDD/1000inhabitants/day). Between 1991 and 2010, the consumption of generic antihypertensives went from 2% to 46%. Antihypertensive consumption increased between 1991 and 2010. However, despite the increase of generic drugs consumption, the levels of antihypertensive consumption remain lower than the needs of hypertensive patients.

References

Mar 5, 1997·JAMA : the Journal of the American Medical Association·B M PsatyC D Furberg
Jan 24, 1998·Lancet·K G SweeneyD P Gray
Sep 3, 1999·BMJ : British Medical Journal·L E RamsayG Russell
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Apr 26, 2003·Journal of Hypertension·Mohammed A TaziJaouad Mahjour
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Mar 25, 2006·Thérapie·Agnès SommetJean-Louis Montastruc
Jun 7, 2006·The Canadian Journal of Cardiology·Arun ChockalingamJ George Fodor
Mar 29, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Andrea SiebenhoferThomas Gratzer
Feb 14, 2008·European Journal of Clinical Nutrition·C L Fischer WalkerR E Black
Jun 20, 2008·Thérapie·Driss Soussi-TananiYahia Cherrah
Oct 8, 2008·Neuroscience Bulletin·Yan-Fen ZhangDa-Yong Wang
Oct 20, 2009·Journal of Hypertension·Giuseppe ManciaUNKNOWN European Society of Hypertension
May 4, 2010·The Journal of Clinical Hypertension·Bonita FalknerFranz Schaefer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

British Journal of Clinical Pharmacology
Sarah Ross, Mary Joan Macleod
BMJ : British Medical Journal
Max Lagnado, Simone Kohll
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Michael Kennedy
© 2021 Meta ULC. All rights reserved